Skip to main content

Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

All Products (346)

Clear all filters
Clear all filters

Cixutumumab

Targeted Therapy (Investigational Antibody / ADC)

Therapeutic Category

Targeted Therapy (Investigational Antibody / ADC)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Investigational Monoclonal / ADC Agent

Coltuximab Ravtansine

Targeted Therapy (Investigational Antibody / ADC)

Therapeutic Category

Targeted Therapy (Investigational Antibody / ADC)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Investigational Monoclonal / ADC Agent

Dalotuzumab

Targeted Therapy (Investigational Antibody / ADC)

Therapeutic Category

Targeted Therapy (Investigational Antibody / ADC)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Investigational Monoclonal / ADC Agent

Dalotuzumab (Ref)

Targeted Therapy (Investigational Antibody / ADC)

Therapeutic Category

Targeted Therapy (Investigational Antibody / ADC)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Investigational Monoclonal / ADC Agent

Daraxonrasib

Targeted Therapy (Investigational)

Therapeutic Category

Targeted Therapy (Investigational)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Pan-RAS(ON) Multi-Selective Tri-Complex Inhibitor

Debio 1347 (FGFR Inhibitor)

Targeted Therapy (Investigational)

Therapeutic Category

Targeted Therapy (Investigational)

Oncology Type

Solid Tumour

Drug Class / Mechanism

FGFR Inhibitor

Denintuzumab Mafodotin

Targeted Therapy (Investigational Antibody / ADC)

Therapeutic Category

Targeted Therapy (Investigational Antibody / ADC)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Investigational Monoclonal / ADC Agent

Devimistat

Targeted Therapy (Investigational)

Therapeutic Category

Targeted Therapy (Investigational)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Metabolic Pathway Inhibitor (IDO/STAT3/Glutaminase)

Duligotuzumab

Targeted Therapy (Investigational Antibody / ADC)

Therapeutic Category

Targeted Therapy (Investigational Antibody / ADC)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Investigational Monoclonal / ADC Agent

Elimusertib

Targeted Therapy (Investigational)

Therapeutic Category

Targeted Therapy (Investigational)

Oncology Type

Solid Tumour

Drug Class / Mechanism

DNA Damage Response Inhibitor

Enavatuzumab

Targeted Therapy (Investigational Antibody / ADC)

Therapeutic Category

Targeted Therapy (Investigational Antibody / ADC)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Investigational Monoclonal / ADC Agent

EOS-448 (Belrestotug)

Immunotherapy (Investigational Checkpoint)

Therapeutic Category

Immunotherapy (Investigational Checkpoint)

Oncology Type

Solid Tumour

Drug Class / Mechanism

TIGIT Inhibitor